![Michael Spigarelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Spigarelli
Technik-/Wissenschafts-/F&E-Leiter bei PSYBIO THERAPEUTICS CORP.
Vermögen: 14 938 $ am 31.05.2024
Profil
Michael Spigarelli is currently the Chief Medical Officer at PsyBio Therapeutics Corp.
He previously held positions as Chairman at American Board of Clinical Pharmacology, Vice President-Medical Affairs at Immucor, Inc., and Chief Medical Officer at Lumen Bioscience, Inc. He holds an MBA from the University of Utah and a doctorate from the University of Michigan.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PSYBIO THERAPEUTICS CORP
2,54% | 05.01.2023 | 2 134 062 ( 2,54% ) | 14 938 $ | 31.05.2024 |
Aktive Positionen von Michael Spigarelli
Unternehmen | Position | Beginn |
---|---|---|
PSYBIO THERAPEUTICS CORP. | Technik-/Wissenschafts-/F&E-Leiter | 05.04.2021 |
Ehemalige bekannte Positionen von Michael Spigarelli
Unternehmen | Position | Ende |
---|---|---|
IMMUCOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
American Board of Clinical Pharmacology, Inc.
![]() American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services American Board of Clinical Pharmacology, Inc. operates as health-related professional association. It provides evaluation for training credentials, preparation and administration for examinations, and register and accredit training programs in clinical pharmacology. in The company is headquartered in San Antonio, TX. | Vorsitzender | - |
Lumen Bioscience, Inc.
![]() Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Spigarelli
University of Utah | Masters Business Admin |
University of Michigan | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PSYBIO THERAPEUTICS CORP. | Health Technology |
Private Unternehmen | 3 |
---|---|
Lumen Bioscience, Inc.
![]() Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Health Technology |
Immucor, Inc.
![]() Immucor, Inc. Medical SpecialtiesHealth Technology Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA. | Health Technology |
American Board of Clinical Pharmacology, Inc.
![]() American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services American Board of Clinical Pharmacology, Inc. operates as health-related professional association. It provides evaluation for training credentials, preparation and administration for examinations, and register and accredit training programs in clinical pharmacology. in The company is headquartered in San Antonio, TX. | Commercial Services |